Read our insights and commentary about industry news and innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.
Showing 5 of 30 posts
September 22, 2020 | Blog
CAR-Ts offer a significant clinical benefit for patients, however their full potential is currently limited by later line use at sites that are mostly academic centers, combined with significant logistical barriers. In CBPartners’ latest thought leadership article, our healthcare consultants look further into these barriers before assessing the opportunities that could bring CAR-Ts into earlier lines of treatment across oncology.
September 17, 2020 | Blog
Hitting the Mark: Lessons Learned From Blockbuster Drugs That Missed or Exceeded Analyst Expectations
Pharmaceutical products can both exceed and fall short of blockbuster sales expectations by considerable margins which can be a result of a number of reasons. Some of these include the value of first-to-market dynamics, supporting real-world evidence to gain a competitive edge, and continual investment in trials for follow-on indications to improve life cycle management.
July 6, 2020 | Blog
Basic science has been redeployed to establish a new understanding of Alzheimer's Disease, focusing on novel biomarkers and cutting-edge therapeutic approaches to slow or reverse disease progression, where the amyloid beta theory has otherwise failed
May 20, 2020 | Podcasts
Andrew Gould asks our US payer panel for their expert perspectives surrounding the management of tumor-agnostic therapies.
May 18, 2020 | Research posters
ISPOR Annual 2020: The Use of Integrated Delivery Networks as Pioneers for Manufacturer HEOR Program / Study Success
A research poster identifying the impact of utilizing Integrated Delivery Networks and their in-house resources in fulfilling HEOR program requirements.